A detailed history of Bli Banque De Luxembourg Investments transactions in Abbott Laboratories stock. As of the latest transaction made, Bli Banque De Luxembourg Investments holds 469,221 shares of ABT stock, worth $62.6 Million. This represents 1.86% of its overall portfolio holdings.

Number of Shares
469,221
Previous 509,521 7.91%
Holding current value
$62.6 Million
Previous $57.5 Billion 6.62%
% of portfolio
1.86%
Previous 1.56%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$111.1 - $140.22 $4.48 Million - $5.65 Million
-40,300 Reduced 7.91%
469,221 $61.3 Billion
Q4 2024

Feb 14, 2025

BUY
$111.93 - $119.39 $57 Million - $60.8 Million
509,521 New
509,521 $57.5 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $234B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bli Banque De Luxembourg Investments Portfolio

Follow Bli Banque De Luxembourg Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bli Banque De Luxembourg Investments, based on Form 13F filings with the SEC.

News

Stay updated on Bli Banque De Luxembourg Investments with notifications on news.